Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of "Pain Gear" in Patients With Chronic Musculoskeletal Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02974023
Recruitment Status : Withdrawn (Study not started due to the Regulatory and administrative issues of Universities in Vietnam)
First Posted : November 28, 2016
Last Update Posted : October 3, 2018
Sponsor:
Collaborator:
BioElectronics Corporation
Information provided by (Responsible Party):
PharmEvo Pvt Ltd

Brief Summary:
The current study was designed to evaluate the effectiveness and safety of the device in the common areas of the body affected by different causes of musculoskeletal pain in Vietnamese population in real life situation.

Condition or disease Intervention/treatment
Chronic Musculoskeletal Disease Device: Pain Gear

Detailed Description:

PainGear [ActiPatch®] (BioElectronics Corporation, MD, USA) has been recently introduced as an 'topical' analgesic for localized musculoskeletal pain. PainGear is a noninvasive, low power, easy to use, pulsed shortwave therapy device for localized musculoskeletal pain. The device does not produce heat or any sensation. There are two basic requirements to use the device, switching it on via an on/off switch, and affixing the device over the target area of the body. The area of treatment is confined to the area within the 11.5-cm diameter loop antenna covering an area of 100 cm2, the antennae is circular, soft and flexible and can be shaped to fit the area/location being treated as required. The device can be used up to 24 h per day and is placed over the area of localized pain either using medical tape or a specifically designed wrap.

In a randomized, double-blind, placebo-controlled clinical trial, patients with radiographic evidence of knee OA (osteoarthritis) and persistent pain higher than 40mm on the visual analog scale (VAS) were recruited. The trial consisted of 12 h daily treatment for 1 month in 60 knee OA patients. After 1 month, PainGear induced a significant reduction in VAS pain and Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores compared with placebo. Additionally, pain tolerance and physical health improved in PainGear -treated patients. Twenty-six per cent of patients in the PainGear group stopped NSAID/analgesic therapy. No adverse events were detected.

Layout table for study information
Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Efficacy of "Pain Gear" in Patients With Chronic Musculoskeletal Pain
Actual Study Start Date : June 30, 2017
Actual Primary Completion Date : October 30, 2017
Estimated Study Completion Date : December 2017

Intervention Details:
  • Device: Pain Gear
    PainGear [ActiPatch®] (BioElectronics Corporation, MD, USA) has been recently introduced as an 'topical' analgesic for localized musculoskeletal pain. PainGear is a noninvasive, low power, easy to use, pulsed shortwave therapy device for localized musculo¬skeletal pain.
    Other Name: ActiPatch


Primary Outcome Measures :
  1. To assess difference in subjective pain with the use of PainGear for 2 weeks. [ Time Frame: 2 weeks ]
    [ Time Frame: Change from baseline visual analogue score over the course of 2 weeks]


Secondary Outcome Measures :
  1. To record change in frequency of other analgesic modalities utilization [ Time Frame: 2 weeks period ]
    [ Time Frame: Change from baseline analgesic modalities usage over the course of 2 weeks period, to be recorded in modalities chart]

  2. To assess difference in Pain-related disability, indexed by the Oswestry Disability Index (ODI) [ Time Frame: 2 weeks, recorded on 1st and 14th day ]
    [ Time Frame: Change from baseline ODI score at 2 weeks, recorded on 1st and 14th day ]

  3. To assess patients satisfaction with two weeks therapy of PainGear [ Time Frame: 14th day ]
    [Time Frame: 14th day]



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients suffering from Low back pain and arthritis.
Criteria

Inclusion Criteria:

  • Chronic musculoskeletal pain of more than 6 month duration
  • Participant is willing and able to give informed consent for participation in the trial.
  • In the Investigator's opinion, is able and willing to comply with all trial requirements.
  • Male or female ages 18-80 years old
  • A current VAS pain rating ≥5/10
  • Able to complete and tolerate treatment for the study period.

Exclusion Criteria:

  • Pregnant Woman
  • Current implanted cardiac demand pacemakers, defibrillators, cardiac pumps, spinal stimulators or other implanted electronic devices.
  • Patients using personal home based electrical stimulation devices
  • Active psychiatric disorders (as evidenced by use of antipsychotic or medication).
  • Patients diagnosed with history of significant mood disorder will be excluded (depression or anxiety with adequate control would be acceptable).
  • Scheduled elective surgery or other procedures requiring general anesthesia during the trial.
  • Participant with life expectancy of less than 6 months, or inappropriate for placebo medication.
  • Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial.
  • Participants who are not able to understand verbal or written English, and for whom adequate translation/interpretation cannot be readily obtained
Layout table for additonal information
Responsible Party: PharmEvo Pvt Ltd
ClinicalTrials.gov Identifier: NCT02974023    
Other Study ID Numbers: PE/PAINGEAR/09/2016
First Posted: November 28, 2016    Key Record Dates
Last Update Posted: October 3, 2018
Last Verified: December 2016
Additional relevant MeSH terms:
Layout table for MeSH terms
Musculoskeletal Pain
Musculoskeletal Diseases
Muscular Diseases
Pain
Neurologic Manifestations